List of SBIR/STTR awards granted to Amplyx Pharmaceuticals

List of SBIR/STTR awards granted to Amplyx Pharmaceuticals

List of SBIR/STTR awards granted to Selenium, Ltd.

List of SBIR/STTR awards granted to Levant Power Corporation

List of SBIR/STTR awards granted to Stara Technologies, Inc.

List of awards received by Georgy Grechko

Companies in the Productivity software industry

where

SBIR/STTR Award Recipient

is

Amplyx Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase II Award, August 2017	A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in August, 2017 for $1,475,794.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R44AI131864-01A1	Phase II	1,475,794	August 18, 2017	sbir.gov/node/1323683
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase II Award, July 2015	A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in July, 2015 for $1,495,390.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	2R44AI106235-03	Phase II	1,495,390	July 1, 2015	sbir.gov/node/1031391
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase II Award, August 2014	A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in August, 2014 for $1,499,498.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	2R44NS079204-03A1	Phase II	1,499,498	August 1, 2014	sbir.gov/node/1048501
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase II Award, June 2014	A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in June, 2014 for $1,499,263.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	2R44AI096844-02A1	Phase II	1,499,263	June 1, 2014	sbir.gov/node/1031409
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase II Award, July 2016	A SBIR Phase II contract was awarded to Amplyx Pharmaceuticals in July, 2016 for $1,460,969.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R44AI125017-01	Phase II	1,460,969	July 1, 2016	sbir.gov/node/1198331
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $558,144.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43AI098300-01A1	Phase I	558,144		sbir.gov/node/399714
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $599,104.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43AI106235-01	Phase I	599,104		sbir.gov/node/677519
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $225,000.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43AI112467-01	Phase I	225,000		sbir.gov/node/705189
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $697,056.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43NS079204-01A1	Phase I	697,056		sbir.gov/node/401028
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $580,422.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43AI098636-01	Phase I	580,422		sbir.gov/node/399736
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $300,000.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43AI096844-01	Phase I	300,000		sbir.gov/node/368113
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $300,959.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43TR000354-01A1	Phase I	300,959		sbir.gov/node/401108
	‌ Amplyx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Amplyx Pharmaceuticals for $696,719.0 USD from the U.S. Department of Health & Human Services.	Amplyx Pharmaceuticals			SBIR	1R43NS083413-01	Phase I	696,719		sbir.gov/node/678376

13 results

0 selected

13 results

0 selected